Part 1: Dr James Robinson on the Impact of 340B Programs and Drug Pricing Policies
In the January issue of The New England Journal of Medicine, James Robinson, PhD, MPH, and his fellow investigators published their findings from an analysis of how insurer drug expenditures on infused drugs influenced price markups at hospitals.